Anakinra therapy in a child with systemic-onset juvenile rheumatoid arthritis after human herpesvirus 6 encephalitis

Area of Science:

• Pediatric Rheumatology
• Infectious Diseases
• Immunology

Background:

• Systemic-onset juvenile idiopathic rheumatoid arthritis (SoJIA) is a significant autoimmune condition in children.
• The etiology of SoJIA remains multifactorial, with potential triggers under investigation.
• Herpesvirus 6 (HHV-6) is a known neurotropic virus, typically causing exanthem subitum in infants.

Observation:

• A 3-year-old patient presented with biopsy-proven HHV-6 encephalitis.
• The patient subsequently developed clinical manifestations consistent with SoJIA.
• The SoJIA-like symptoms showed a positive response to interleukin-1 (IL-1) receptor antagonist therapy.

Findings:

• The clinical course suggests a potential temporal relationship between HHV-6 infection and the onset of SoJIA.
• The therapeutic response to IL-1 receptor blockade indicates the likely involvement of IL-1 in the pathogenesis of this patient's SoJIA.
• This case contributes to the understanding of IL-1 receptor antagonist therapy in SoJIA.

Implications:

• HHV-6 infection should be considered as a potential trigger for new-onset SoJIA.
• Future prospective studies on new-onset SoJIA should incorporate screening for HHV-6 infection.
• Further research may elucidate the role of viral infections in the development of autoimmune conditions like SoJIA.